Crizotinib/osimertinibIntermittent fatigue: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1662卷 / 1期

关键词：

D O I：

10.1007/s40278-017-33741-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：111 / 111

相关论文

共 50 条

[21] Catequentinib/crizotinib/icotinibLack of efficacy: case report
Reactions Weekly, 2022, 1932 (1) : 171 - 171
[22] Alectinib/crizotinib/nivolumabLack of efficacy: case report
Reactions Weekly, 2023, 1967 (1) : 25 - 25
[23] Crizotinib/Nedaplatin/PemetrexedVarious toxicities: case report
Reactions Weekly, 2025, 2049 (1) : 121 - 121
[24] Crizotinib/everolimus interactionVarious toxicities: case report
Reactions Weekly, 2020, 1822 (1) : 105 - 105
[25] CrizotinibDevelopment of crizotinib resistance: case report.
Reactions Weekly, 2020, 1820 (1) : 113 - 113
[26] Ceritinib/crizotinib/lorlatinibDrug resistance: case report
Reactions Weekly, 2018, 1702 (1) : 73 - 73
[27] Cisplatin/crizotinib/pemetrexedTreatment failure: case report
Reactions Weekly, 2023, 1950 (1) : 124 - 124
[28] Crizotinib/erlotinibSkin and visual toxicity: case report
Reactions Weekly, 2015, 1544 (1) : 82 - 82
[29] Alectinib/crizotinib/lorlatinibDrug resistance: case report
Reactions Weekly, 2020, 1798 (1) : 22 - 22
[30] Crizotinib/pemetrexedColitis, malaise and nausea: case report
Reactions Weekly, 2017, 1658 (1) : 148 - 148

← 1 2 3 4 5 →